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Edited by Amy McGoughAbstract Myopodin is an actin bundling protein that shuttles
between nucleus and cytoplasm in response to cell stress or dur-
ing diﬀerentiation. Here, we show that the myopodin sequence
58KKRRRRARK66, when tagged to either enhanced green ﬂuo-
rescent protein (EGFP) or to enhanced cyan ﬂuorescent pro-
tein-CapG (ECFPCapG), is able to target these proteins to the
nucleolus in HeLa or HEK293T cells. By contrast, 58KKRR61-
ECFP-CapG accumulates in the nucleus. Mutation of
58KKRRRRARK66 into alanine residues blocks myopodin nucle-
ar import and promotes formation of cytoplasmic actin ﬁla-
ments. A second putative nuclear localization sequence,
612KTSKKKGKK620, displays much weaker activity in a heterol-
ogous context, and appears not to be functional in the full length
protein. Thus myopodin nuclear translocation is dependent on a
monopartite nuclear localization sequence.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Many physiological processes like cell migration, adhesion,
division and development are accompanied by cytoskeletal
rearrangements, and occur by virtue of actin binding proteins
[1] that reversibly organize actin monomers into ﬁlamentous
structures. Within this large group of actin binding proteins,
many of which are expressed simultaneously in eukaryotic
cells, actin bundling proteins take up a prominent role by
cross-linking ﬁlaments into tight bundles allowing cells to per-
form distinct functions. In recent years, there has been a
noticeable trend towards research focusing on nuclear actin
binding proteins.
Nucleocytoplasmic protein traﬃcking occurs through nucle-
ar pore complexes embedded in the nuclear membrane, and isAbbreviations: b-gal, beta-galactosidase; ECFP, enhanced cyan
ﬂuorescent protein; EGFP, enhanced green ﬂuorescent protein; NLS,
nuclear localization sequence
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doi:10.1016/j.febslet.2005.10.054mediated by transport receptors called importins and expor-
tins. These in turn recognize transport signals in their cargoes
known as nuclear localization signals and nuclear export sig-
nals [2,3], resulting in translocation through the nuclear pore
complex via interaction with nucleoporins, the basic constitu-
ents of the nuclear pore complex. Actin binding proteins such
as CapG [4,5], plastins/ﬁmbrins [6], proﬁlin [7,8], thymosin [9],
supervillin [10] and Flightless I [11], among others, have been
observed to shuttle between the cytoplasm and nucleus of
eukaryotic cells. While it is not entirely clear in each case which
role(s) these proteins perform in the nucleus, is has been shown
that some of them can modulate gene transcription controlled
by steroid hormone receptors [12,13].
Myopodin is an actin bundling protein that shuttles between
nucleus and cytoplasm in a diﬀerentiation-dependent manner
in muscle cells; its nuclear localization in myoblasts shifts to
the cytoplasm and Z-disc as muscle cells diﬀerentiate into myo-
tubes [14]. Myopodin is also expressed in other tissues and
(cancer) cells [15,16] where it localizes to the nucleus and cyto-
plasm. We identiﬁed a weak nuclear export sequence in myo-
podin that is able to export an otherwise nuclear protein [5]
but as such little is known about myopodin key sequences that
control its nuclear import. Here we show that this is regulated
by a monopartite nuclear localization sequence (NLS).2. Materials and methods
2.1. Reagents
Texas Red-X-phalloidin, Alexa ﬂuor 488 conjugated goat anti-
mouse IgG and Alexa ﬂuor 594 conjugated goat anti-mouse IgG
were fromMolecular Probes (Eugene, OR). Anti-V5 antibody andHiFi
Platinum Taq polymerase were purchased from Invitrogen (Merelbeke,
Belgium). Anti-GFP was obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Monoclonal anti-B23 (Nucleophosmin/
NPM) clone EA-53, cytochalasin D and 4,6-diamidino-2-phenylindole
(DAPI) were obtained from Sigma (St. Louis, USA). Restriction
enzymes were from New England Biolabs (Beverly, MA). Pfu turbo
polymerase and Quikchange site-directed mutagenesis kit were from
Stratagene (La Jolla, CA,USA).
2.2. cDNA cloning and constructs
pcDNA3.1/V5-His-myopodin was described previously [5]. Myopo-
din was subcloned into the pEGFP-N1 vector (BD Biosciences) as an
EcoRI/BamHI fragment. The myopodin fragment 56M–P432 was cre-
ated by a AgeI digest and a subsequent ligation; the deletion frag-
ment 219M–E758 was obtained by a SacI digest and subsequent
ligation. Fusion proteins and mutants were created using partiallyblished by Elsevier B.V. All rights reserved.
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by sequencing. The EGFP-b-gal construct was generously provided
by Prof. Dr. M. Bollen (Division of Biochemistry, KU Leuven, Bel-
gium). CapG in the pECFP-C1 vector (BD Biosciences Clontech) was
adapted for gateway cloning [17].
2.3. Cell culture and transfection
HEK293T cells and HeLa cells were maintained as described [18].
HeLa cells were transiently transfected using lipofectamine reagent
(Invitrogen, Merelbeke, Belgium) according to the manufacturers
instructions. HEK293T cells, seeded on rat tail collagen-coated cover-
slips, were transfected using calcium phosphate. HeLa cells were incu-
bated with 0.2 lM cytochalasin D starting at 8 h post-transfection for
16 h. Subsequently, the cells were processed for ﬂuorescence micros-
copy. Quantiﬁcation of nucleocytoplasmic distribution of fusion pro-
teins was performed by scoring 100 cells (cytoplasmic only, or
cytoplasmic and nuclear). Experiments were performed in triplicate.
Mean values and S.D. were calculated. Axiovision 4.4 software (Zeiss,
Go¨ttingen) was used to calculate the ratio of nuclear ﬂuorescence ver-
sus cytoplasmic ﬂuorescence in transfected cells.
2.4. Fluorescence microscopy and immunocytochemistry
Staining of cells and ﬂuorescence microscopy were performed as de-
scribed [6]. Confocal microscopy was done with a LSM- 510 CLSM
microscope equipped with software package LSM510 version 3.2
(Zeiss) as described in more detail in [19].2.5. Miscellaneous
Lysis of cells and Western blot analysis were performed as described
[20]. Proteins were visualized by enhanced chemiluminescence detec-
tion (ECL, Amersham Pharmacia Biotech, Buckinghamshire, UK).
Protein concentrations were determined by the method of Bradford
[21] using bovine serum albumin as a standard.3. Results
3.1. Myopodin deletion fragments exhibit a diﬀerential
localization in cells
A previous study [14] showed that two putative nuclear
localization signals of myopodin, 58KKRR61 and
616KKGK619, were not functional because mutation of two ly-
sine residues in these sequences (58AARR61; 616AAGK619) did
not aﬀect the localization of the actin binding protein. Initially,
we studied nuclear targeting of myopodin in various cell types
using enhanced green ﬂuorescent protein (EGFP)-tagged trun-
cation variants of myopodin (Fig. 1A). Full length myopodin-
EGFP localized to the nucleus and cytoplasm (also onto actin
stress ﬁbers) following expression in HeLa cells, but stronger
nuclear enrichment was observed in HEK293T cells
(Fig. 1B). The myopodin fragment 56M–P432, tagged to EGFP,
lacks the nuclear export sequence 3P–L24 [5] and localized to
the nucleus and cytoplasm in HeLa or HEK293T cells
(Fig. 1C). Nuclear entry by passive diﬀusion of this fusion pro-
tein is unlikely because its molecular mass exceeds 60 kDa,
which is above the limit for passive diﬀusion [22]. By contrast,
expression of myopodin 219M–E758-EGFP promoted a subcel-
lular distribution in HeLa cells consisting of a ﬁber-like pattern
in the cytoplasm, due to association with actin ﬁlaments
(Fig. 1D, left). No nuclear enrichment of this myopodin trun-
cation mutant was observed in HEK293T cells either (Fig. 1D,
right). Expression of these constructs was conﬁrmed by Wes-
tern blotting (Fig. 1E), and quantiﬁcation of data for HeLa
cells is depicted in Fig. 1F. The nuclear localization of myopo-
din-EGFP constructs in HEK293T cells was observed in close
to 100% of the cells. Full length myopodin-EGFP and myopo-din 56M–P432-EGFP displayed a nuclear/cytoplasmic ratio of
1.66 and 1.56 (arbitrary units), respectively, while the ratio
of myopodin 219M–E758-EGFP was 0.70. These ﬁndings
strongly suggest that the myopodin fragment 56M–Q218 har-
bors a nuclear targeting sequence.
3.2. Nuclear/nucleolar shuttling of reporter proteins by
myopodin targeting sequences
Thorough analysis of the amino acid sequence of the 56M–
Q218 myopodin fragment revealed only one potential mono-
partite NLS, 58KKRRRRARK66 (NLS1), that overlaps with
the putative NLS previously reported by Weins et al. [14]
(58KKRR61). Surprisingly, when the sequence 58KKRRRR-
ARK66 (NLS1) was coupled to EGFP, we noticed strong
enrichment in nucleoli of HEK293T and HeLa cells, suggest-
ing that this region could act as a nucleolar targeting sequence
(Fig. 2A, top panel). This ﬁnding led us to re-investigate the
equally ineﬀective 616KKGK619 NLS2 sequence in a broader
context. Coupling of 612KTSKKKGKK620 (NLS2) to EGFP
also promoted nucleolar targeting (Fig. 2A, bottom panel). Be-
cause EGFP shows a strong tendency to accumulate in the
nucleus through passive diﬀusion, the myopodin 58KKRRRR-
ARK66/612KTSKKKGKK620 sequences were also tagged to
enhanced cyan ﬂuorescent protein (ECFP)-CapG, a 67 kDa
fusion protein that is not enriched in the nucleus when the ﬂuo-
rescent protein is tagged to the amino terminus of CapG
(Fig. 2B, left panels). We observed nucleolar ﬂuorescence for
myopodin NLS1-ECFP-CapG in various cell types, as evi-
denced by co-staining with the nucleolar marker nucleophos-
min (B23) (Fig. 2B). These ﬁndings were conﬁrmed by
confocal microscopy (data not shown). By contrast,
612KTSKKKGKK620 (NLS2)-tagged ECFP-CapG remained
entirely cytoplasmic (data not shown). As mutation of both ly-
sine residues in the sequence 58KKRR61 did not aﬀect myopo-
din localization [14], we coupled all four residues 58KKRR61 to
ECFP-CapG and compared its targeting activity to
58KKRRRRARK66. Interestingly, this fusion protein exhib-
ited strong ﬂuorescence in the nucleus, but not in the nucleolus
(Fig. 3A). Myopodin NLS1, NLS2 or the 58KKRR61 sequence
were also expressed as a fusion protein with EGFP- b-gal,
resulting in a large tetrameric polypeptide of >500 kDa. In
HeLa or HEK293T cells we noted that both myopodin
NLS1 and the 58KKRR61 sequence strongly enhanced nuclear,
but not nucleolar, accumulation of EGFP-b-gal. NLS2 was
unable to target EGFP-b-gal to the nucleus (Fig. 3B). As such
our ﬁndings suggest that 58KKRRRRARK66 and 58KKRR61
can be classiﬁed as a strong NLS while 612KTSKKKGKK620
is unable to target medium size or large proteins autonomously
to the nucleus.3.3. Mutation of the myopodin sequence 58KKRRRRARK66
prevents nuclear targeting and promotes cytoplasmic actin
ﬁlament association
The role of both NLS1 and NLS2 in regulating the localiza-
tion of myopodin was investigated by mutating all basic amino
acids into alanine (58KKRRRRARK66 to 58AAAAAAAAA66
for NLS1 and 612KTSKKKGKK620 to 612ATSAAAGAA620
for NLS2), rather than deleting them as this could disturb
the structure of myopodin more profoundly, and therefore
hamper interaction with other proteins. Because myopodin
shows a strong tendency to associate with actin stress ﬁbers
Fig. 1. Localization of myopodin-EGFP and truncation mutants in cells. (A) Schematic diagram depicting full length myopodin and deletion
fragments 56M–P432 and 219M–E758, fused to EGFP. NES, nuclear export sequence; NLS, nuclear localization sequence. (B) Full length myopodin-
EGFP localizes to the nucleus and cytoplasm of HeLa (left) and HEK293T cells (right). (C) Myopodin 56M–P432-EGFP is strongly enriched in the
nucleus. (D) The myopodin fragment 219M–E758-EGFP is not enriched in the nucleus. Corresponding DAPI images are shown. Bar = 20 lm. (E)
western blot showing expression of myopodin (lane 1), the 56M–P432 fragment (lane 2) and the 219M–E758 fragment (lane 3) in HeLa cells using anti-
GFP antibody. (F) Histogram showing the proportion of cells displaying cytoplasmic (C) or cytoplasmic + nuclear distribution of myopodin
constructs in HeLa cells. Data are means ± S.E. of three independent experiments. FL, full length.
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D (see Section 2). This promoted disruption of actin stress ﬁ-
bers (not shown) but facilitated myopodin nuclear entry, thus
allowing a more balanced comparison with HEK293T cells.
Expression in HeLa or HEK293T cells of a myopodin cDNA
in which NLS2 was mutated (Myo NLS2Ala) did not promote
a signiﬁcant change in subcellular localization (Fig. 4A, com-
pare with wild type): Myo NLS2Ala predominantly stained
the nucleus in HEK293T cells, as did the wild type protein.Similarly, wild type myopodin and Myo NLS2Ala stained
the nucleus and short actin ﬁbers in HeLa cells (Fig. 4A). By
contrast, Myo NLS1Ala no longer localized to the nucleus in
HeLa or HEK293T cells, and promoted formation of extended
actin ﬁlaments or actin loops in 46 ± 3.9% of HEK293T cells
observed (Fig. 4B, upper panels, arrowheads). Confocal
microscopy conﬁrmed co-localization between actin ﬁlaments
and Myo NLS1Ala (data not shown). A cytoplasmic localiza-
tion of this mutated protein without formation of extended
Fig. 2. Nuclear and nucleolar targeting of heterologous proteins by myopodin NLS1 or NLS2. (A) Myopodin NLS1-EGFP or NLS2-EGFP
accumulate in nucleoli of HeLa and HEK293T cells. (B) The cytoplasmic localization of ECFP-CapG in HEK293T, HeLa or C2C12 cells (left
panels) shifts to nucleoli when ECFP-CapG is tagged with myopodin NLS1, as evidenced by anti-B23 staining. Bar = 20 lm.
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neous mutation of all basic amino acids of both NLS1 and
NLS2 (Myo NLS1 + 2Ala) showed a phenotype similar to
Myo NLS1Ala (Fig. 4C), and 44 ± 4.0% of HEK293T cells
exhibited cytoplasmic actin loops. Mutation in myopodin of
the ﬁrst four basic residues of NLS1 (58KKRR61–58AAAA61)
also prevented nuclear entry of myopodin, nearly as eﬃciently
as NLS1 (Fig. 4D). It is not clear at present why cytoplasmic
actin ﬁlaments were observed in a smaller number of cells here
(10 ± 5%). Quantiﬁcation of these data is shown in Fig. 5. Ta-
ken together, our ﬁndings indicate that NLS1 is necessary and
suﬃcient to regulate subcellular targeting of myopodin in cells,
with 58KKRR61 representing the minimal fragment.4. Conclusion
We have presented evidence that myopodin harbors a single
regulatory sequence required to target the protein to the nu-
cleus. Mutation of 58KKRRRRARK66 (NLS1) or 58KKRR61
is necessary and suﬃcient to prevent nuclear accumulation ofmyopodin. Of note, p73 [23], a member of the p53 family of
proteins, and the ubiquitin-activating enzyme [24] are also tar-
geted to the nucleus via a KKRR sequence. However the
KKRR sequence of the IL-1a propiece is required but not suf-
ﬁcient to localize it to the nucleus [25].
Using ﬂuorescent reporter proteins with molecular masses
ranging from small to large sizes we have demonstrated that
myopodin 58KKRRRRARK66 targets ECFP-CapG to nucle-
oli whereas the shorter sequence 58KKRR61 translocates
ECFP-CapG to nuclei. This ﬁnding is reminiscent of the
NF-jB inducing kinase NIK, a protein that harbors a se-
quence 143RKKRKKK149 targeting NIK to nucleoli when nu-
clear export sequences of the kinase are deleted [26]. By
contrast, NIK 143AAAAKKK149 prevents translocation into
nucleoli while retaining its nuclear accumulation.
Although unexpected, it is not unprecedented that nuclear
localization sequences fail to mediate nuclear/nucleolar accu-
mulation of large carrier molecules like beta-galactosidase in
contrast to small or medium size reporter proteins. Indeed,
in this respect our ﬁnding that NLS1 translocates ECFP-CapG
to nucleoli but not EGFP-b-gal, is similar to that reported for
Fig. 3. The myopodin NLS1 fragment 58KKRR61 possesses nuclear targeting activity. (A) 58KKRR61 promotes nuclear, but not nucleolar,
accumulation of ECFP-CapG. Bar = 20 lm. (B) Myopodin NLS1 or the 58KKRR61 NLS1 fragment directs EGFP-b-gal to the nuclei of HeLa or
HEK293T cells, but not to nucleoli; NLS2 is unable to mimick this eﬀect. Bar = 20 lm.
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[27], HIV-Tat [28] and mouse upstream binding factor [29].
It is diﬃcult to gauge at present whether the myopodin
nucleolar targeting sequences are physiologically relevant.
However, although myopodin is a genuine dynamic shuttling
protein, changing its localization during diﬀerentiation from
nucleus to cytoplasm/actin ﬁbers, but apparently absent from
nucleoli, a nucleolar localization of endogenous or overexpres-
sed myopodin can be clearly discerned in various bladder can-
cer cell lines [16]. Since myopodin NLS2 is able to target
EGFP, but not ECFP-CapG or EGFP-b-galactosidase to
nucleoli, we cannot rule out at present that this sequence
may contribute to nucleolar localization of myopodin (i.e.,
during speciﬁc stages of diﬀerentiation or in cancer cells). This
would be similar to the human ribosomal L7a protein where
nucleolar targeting requires a basic domain represented by
an NLS or a stretch of basic amino acids without NLS activity,
in addition to another domain [30].
Our ﬁndings are at variance with a recent report showing
that deletion in myopodin of either 58KKRR61 or of
616KKGKK620 prevents its translocation to the nucleus [31],suggesting that myopodin contains two nuclear localization se-
quences. However, these authors also observed that mutation
of two basic residues in these sequences has no eﬀect on myo-
podin localization [14]. We consider it not unlikely that delet-
ing these sequences aﬀects the overall structure and biological
properties of myopodin more severely than mutating them.
While the function of myopodin in the nucleus remains un-
clear at present, recent studies have shown that several (cyto-
plasmic) actin binding proteins are able to enter the nucleus
transiently, and modulate transactivation activity of various
nuclear steroid receptors (reviewed in [13]). For instance, a-ac-
tinin2 (a bona ﬁde actin crosslinking protein) enhances andro-
gen receptor activity, most likely through its LXXLL motif
[32], a signature sequence typical of receptor coactivators
[33]. Since myopodin also contains an LXXLL motif
(372LLSLL376) we speculate that nuclear receptors could repre-
sent a target for nuclear myopodin. Alternatively, nuclear
myopodin could modulate gene transcription by regulating
the interaction between actin and RNA polymerase II. Indeed,
nuclear actin is a component of the RNA polymerase II-con-
taining preinitiation complex [34] and as such indispensable
Fig. 4. Mutation of myopodin NLS1 blocks nuclear accumulation. (A) Localization of V5 epitope tagged myopodin in HeLa or HEK293T cells
(upper panels). Mutation of NLS2 (MyoNLS2Ala) has no signiﬁcant eﬀect on the localization of myopodin (lower panels). (B) Mutation of NLS1
(MyoNLS1Ala) abolishes nuclear import, and promotes formation of cytoplasmic actin ﬁlaments in HEK293T cells (right, arrowheads). Cells shown
in the lower panel lack pronounced actin loops but illustrate the cytoplasmic localization of this myopodin mutant. (C) Simultaneous mutation of
both NLS1 and NLS2 (Myo NLS1 + 2Ala) yields a phenotype similar to Myo NLS1Ala. The arrow highlights an untransfected cell with few or no
actin ﬁbers. (D) Mutation of the 58KKRR61 fragment of NLS1 also prevents myopodin nuclear translocation. Corresponding DAPI images are
shown. Bar = 20 lm.
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Fig. 5. Histogram displaying the proportion of cells with cytoplasmic
(C) or cytoplasmic + nuclear distribution of wild type (WT) or
mutated myopodin constructs in HeLa cells (crossed bars) and
HEK293T cells (white bars). Data are means ± S.E. of three indepen-
dent experiments.
A. De Ganck et al. / FEBS Letters 579 (2005) 6673–6680 6679for gene transcription. Further studies are warranted to con-
ﬁrm this hypothesis.
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